A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study
Public ClinicalTrials.gov record NCT02218008. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Efficacy and Safety Study of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder (the FORWARD-5 Study)
Study identification
- NCT ID
- NCT02218008
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Alkermes, Inc.
- Industry
- Enrollment
- 407 participants
Conditions and interventions
Conditions
Interventions
- ALKS 5461 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2014
- Primary completion
- Aug 31, 2016
- Completion
- Sep 30, 2016
- Last update posted
- Aug 13, 2019
2014 – 2016
United States locations
- U.S. sites
- 32
- U.S. states
- 17
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alkermes Investigational Site | Birmingham | Alabama | 35294 | — |
| Alkermes Investigational Site | Colton | California | 92324 | — |
| Alkermes Investigational Site | Garden Grove | California | 92845 | — |
| Alkermes Investigational Site | Los Angeles | California | 90024 | — |
| Alkermes Investigational Site | Oakland | California | 94612 | — |
| Alkermes Investigational Site | Oceanside | California | 92056 | — |
| Alkermes Investigational Site | Pico Rivera | California | 90660 | — |
| Alkermes Investigational Site | San Gabriel | California | 91776 | — |
| Alkermes Investigational Site | Colorado Springs | Colorado | 80910 | — |
| Alkermes Investigational Site | Bradenton | Florida | 34201 | — |
| Alkermes Investigational Site | Fort Myers | Florida | 33912 | — |
| Alkermes Investigational Site | Melbourne | Florida | 32901 | — |
| Alkermes Investigational Site | North Miami | Florida | 33161 | — |
| Alkermes Investigational Site | Oakland Park | Florida | 33334 | — |
| Alkermes Investigational Site | Winter Haven | Florida | 33880 | — |
| Alkermes Investigational Site | Smyrna | Georgia | 30080 | — |
| Alkermes Investigational Site | Hoffman Estates | Illinois | 60169 | — |
| Alkermes Investigational Site | Flowood | Mississippi | 39232 | — |
| Alkermes Investigational Site | Saint Charles | Missouri | 63304 | — |
| Alkermes Investigational Site | St Louis | Missouri | 63141 | — |
| Alkermes Investigational Site | Princeton | New Jersey | 08540 | — |
| Alkermes Investigational Site | New York | New York | 10168 | — |
| Alkermes Investigational Site | High Point | North Carolina | 27265 | — |
| Alkermes Investigational Site | Canton | Ohio | 44718 | — |
| Alkermes Investigational Site | Portland | Oregon | 97214 | — |
| Alkermes Investigational Site | Memphis | Tennessee | 38119 | — |
| Alkermes Investigational Site | DeSoto | Texas | 75115 | — |
| Alkermes Investigational Site | Wichita Falls | Texas | 76309 | — |
| Alkermes Investigational Site | Clinton | Utah | 84015 | — |
| Alkermes Investigational Site | Bellevue | Washington | 98007 | — |
| Alkermes Investigational Site | Seattle | Washington | 98104 | — |
| Alkermes Investigational Site | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02218008, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 13, 2019 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02218008 live on ClinicalTrials.gov.